AstraZeneca Shareholders Revolt Again Over Executive Pay - theguardian.com -BoardProspects

AstraZeneca Shareholders Revolt Again Over Executive Pay

theguardian.com Apr 28 2017 BoardNews

AstraZeneca has suffered another shareholder revolt over executive pay, with two-fifths opposing a £13m package for its chief executive. Nearly 39% of investors voted against the pharmaceutical group’s 2016 remuneration report at its annual meeting in London, similar to the rebellion it faced three years ago . Support for the new pay policy was much stronger, with 96% of investors backing it...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
- Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
- Have the Swiss Gone Cuckoo? also categorized in BoardNews
- BT investors vent anger at bonus also published in theguardian.com
- Hewlett-Packard Shakes Up Management, Raises Outlook also mentions Management
- A corporation without a proper corporate structure also published in theguardian.com
- Germany's Corporate Governance Problem also categorized in BoardNews
- Public Anger Over Pay is Serious Threat to UK Business, IoD Survey Finds also written by Julia Kollewe
- Why Should We Care About Corporate Interlocks? also categorized in BoardNews
- The Other Duty of Corporate Governance also categorized in BoardNews

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned
Authors
- Julia Kollewe